In lung adenocarcinoma, PHF5A functioned as an oncoprotein to inhibit cisplatin-induced apoptosis, facilitate cell proliferation, migration and invasion, as well as G0/G1 cell cycle progression [29]. Here, PHF5A is linked to lung adenocarcinoma.